# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-046135
Filing Date
2025-12-19
Accepted
2025-12-19 09:26:26
Documents
7

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ef20061157_defa14a.htm | DEFA14A | 956380
2 |  | ef20061157_ex99-7slide1.jpg | GRAPHIC | 221098
3 |  | ef20061157_ex99-7slide2.jpg | GRAPHIC | 365257
4 |  | image0.jpg | GRAPHIC | 8820
5 |  | image00001.jpg | GRAPHIC | 48891
6 |  | image00002.jpg | GRAPHIC | 3305
7 |  | image00004.jpg | GRAPHIC | 4673
| Complete submission text file | 0001140361-25-046135.txt |  | 1856305

Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33497 | Film No.: 251585527
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)